The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dobrokhotova Yu.E.

Pirogov Russian National Research Medical University

Bondarenko K.R.

Pirogov Russian National Research Medical University

Shadrova P.A.

Pirogov Russian National Research Medical University

Current view on infectious factor of early reproductive losses and possible pathogenetic mechanisms

Authors:

Dobrokhotova Yu.E., Bondarenko K.R., Shadrova P.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2020;26(3): 23‑30

Read: 4720 times


To cite this article:

Dobrokhotova YuE, Bondarenko KR, Shadrova PA. Current view on infectious factor of early reproductive losses and possible pathogenetic mechanisms. Russian Journal of Human Reproduction. 2020;26(3):23‑30. (In Russ.)
https://doi.org/10.17116/repro20202603123

Recommended articles:
Early pregnancy loss: the influence of endo­genous risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):50-58
Rela­tionship between meta­bolic syndrome components and pathology of the red border of the lips and oral mucosa. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(4-2):58-63
Retrospective analysis of sexually transmitted infe­ctions inci­dence in countries of the world. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):132-142
Bacterial vagi­nosis: modern views. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):261-268
Lactobacilli and bacterial vagi­nosis. Species typing and analysis of content levels in the microbiome. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(2):43-50
Correction of vagi­nal microbiocenosis in bacterial vagi­nosis. Promising areas. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):44-50

References:

  1. Alijotas-Reig J, Garrido-Gimenez C. Current concepts and new trends in the diagnosis and management of recurrent miscarriage. Obstetrical and Gynecological Survey. 2013;68(6):445-466.  https://doi.org/10.1097/OGX.0b013e31828aca19
  2. Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case—control study. Human Reproduction. 2002;17(2):446-451.  https://doi.org/10.1093/humrep/17.2.446
  3. Giakoumelou S, Wheelhouse N, Cuschieri K, EntricanG, Howie SEM, Horne AW. The role of infection in miscarriage. Human Reproduction Update. 2016;22(1):116-133.  https://doi.org/10.1093/humupd/dmv041
  4. González Pedraza Avilés A, Ortíz Zaragoza MC, Irigoyen Coria A. Bacterial vaginosis a «broad overview». Revista Latinoamericana de Microbiología. 1999;41(1):25-34. 
  5. Sobel JD. Vulvovaginitis in healthy woman. Comprehensive Therapy. 1999;25(6-7):335-346.  https://doi.org/10.1007/BF02944280
  6. Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG: An International Journal of Obstetrics and Gynaecology. 2002;109(1):34-43.  https://doi.org/10.1111/j.1471-0528.2002.00432.x
  7. Sobel JD, Subramanian C, Foxman B, Fairfax M, Gygax SE. Mixed vaginitis-more than coinfection and with therapeutic implications. Current Infectious Disease Reports. 2013;15(2):104-108.  https://doi.org/10.1007/s11908-013-0325-5
  8. Brewster JA, Orsi NM, Gopichandran N, Ekbote UV, Cadogan E, Walker JJ. Host inflammatory response profiling in preeclampsia using an in vitro whole blood stimulation model. Hypertension in Pregnancy. 2008;27(1):1-16.  https://doi.org/10.1080/10641950701826067
  9. Bizargity P, Del Rio R, Phillippe M, Teuscher C, Bonney EA. Resistance to lipopolysaccharide-induced preterm delivery mediated by regulatory T cell function in mice. Biology of Reproduction. 2009; 80(5):874-881.  https://doi.org/10.1095/biolreprod.108.074294
  10. Girard S, Tremblay L, Lepage M, Sébire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. Journal of Immunology. 2010; 184(7):3997-4005. https://doi.org/10.4049/jimmunol.0903349
  11. Nigro G, Mazzocco M, Mattia E, Carlo Di Renzo G, Carta G, Anceschi MM. Role of the infections in recurrent spontaneous abortion. Journal of Maternal-Fetal and Neonatal Medicine. 2011;24:983-989.  https://doi.org/10.3109/14767058.2010.547963
  12. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F. Inflammation and pregnancy. Reproductive Sciences. 2009;16(2):206-215.  https://doi.org/10.1177/1933719108329095
  13. Dobrokhotova YuE, Bondarenko KR, Gushchin AE, Rumyantseva TA, Dolgova TV, Kuznetsov PA, Dzhokhadze LS. Results of real-time PCR study of cervico-vaginal microbiota in pregnant women with threatening preterm birth. Akusherstvo i ginekologiia. 2018; 11:50-59. (In Russ.). https://doi.org/10.18565/aig.2018.11.50-59
  14. Pararas MV, Skevaki CL, Kafetzis DA. Preterm birth due to maternal infection: Causative pathogens and modes of prevention. European Journal of Clinical Microbiology and Infectious Diseases. 2006; 25(9):562.  https://doi.org/10.1007/s10096-006-0190-3
  15. Jensen JS. Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis. Danish Medical Bulletin. 2006;53(1):1-27. 
  16. Maeda S, Deguchi T, Ishiko H, Matsumoto T, Naito S, Kumon H, Tsukamoto T, Onodera S, Kamidono S. Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization. International Journal of Urology. 2004;11(9):750-754.  https://doi.org/10.1111/j.1442-2042.2004.00887.x
  17. Taylor-Robinson D, Tully JG. Mycoplasmas, Ureaplasmas, Spiroplasmas and Related Organisms. In: Top-ley and Wilson’s Systematic Bacteriology. Balows A., Duerden B.I., eds, 9th ed. London: Arnold; 1998: 799-827. 
  18. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clinical Infectious Diseases. 2015;61(3):418-426.  https://doi.org/10.1093/cid/civ312.
  19. Potekaev NN, Kisina VI, Romanova IV, Gushchin AE, Polevshchikova SA. Current state of the research on Mycoplasma genitalium infection. Klinicheskaya dermatologiya i venerologiya. 2018;3:12-21. (In Russ.). https://doi.org/10.17116/klinderma201817312
  20. Bondarenko KR. Pozdnie akusherskie oslozhneniya, associirovannye s gramotricatel’nymi bakterial’nymi infekciyami. Patogenez, klinika, diagnostika i profilaktika: Dis. ... d-ra med. nauk. M. 2018. (In Russ.).
  21. Pilawski Z, Malecha J. Trichomonads and the pregnancy: therapeutic problems. Wiadomości Parazytologiczne. 1983;29:187-190. 
  22. Forna F, Gülmezoglu AM. Interventions for treating trichomoniasis in women. The Cochrane Database of Systematic Reviews. 2003; 2:CD000218. https://doi.org/10.1002/14651858.CD000218
  23. Gülmezoglu AM, Azhar M. Interventions for trichomoniasis in pregnancy. The Cochrane Database of Systematic Reviews. 2011;5: CD000220. https://doi.org/10.1002/14651858.CD000220.pub2
  24. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. Journal of Clinical Investigation. 1997;99(1):77-87.  https://doi.org/10.1172/JCI119136
  25. Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends in Microbiology. 2003;11(1):44-51.  https://doi.org/10.1016/s0966-842x(02)00011-2
  26. Baud D, Goy G, Jaton K, Osterheld M-Ch, Blumer S, Borel N, Vial Y, Hohlfeld P, Pospischil A, Greub G. Role of Chlamydia trachomatis in Miscarriage. Emerging Infectious Diseases. 2011;17(9):1630-1635. https://doi.org/10.1186/s12884-018-1868-0
  27. Oakeshott P, Hay Ph, Hay S, Steinke F, Rink E, Kerry S. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks’ gestation: prospective community based cohort study. BMJ. 2002;325(7376):1334. https://doi.org/10.1136/bmj.325.7376.1334
  28. Holmes KK, Mårdh P-A, Sparling PF, Lemon SM, Stamm WE, Piot P, Wasserheit JN (ed.). Sexually transmitted diseases. 3rd ed. Toronto: McGraw-Hill Information Services Company; 1990.
  29. Fichorova RN, Desai PJ, Gibson III FC, Genco CA. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infection and Immunity. 2001;69:5840-5848. https://doi.org/10.1128/iai.69.9.5840-5848.2001
  30. Källström H, Blackmer Gill D, Albiger B, Liszewski MK, Atkinson JP, Jonsson A-B. Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell Microbiology. 2001;3:133-143.  https://doi.org/10.1046/j.1462-5822.2001.00095.x
  31. Liu B, Roberts CL, Clarke M, Jorm L, Hunt J, Ward J. Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: a retrospective cohort study. Sexually Transmitted Infections. 2013;89(8):672-678.  https://doi.org/10.1136/sextrans-2013-051118
  32. Morris M, Nicoll A, Simms I, Wilson J, Catchpole M. Bacterial vaginosis: a public health review. BJOG. 2001;108(5):439-450.  https://doi.org/10.1111/j.1471-0528.2001.00124.x
  33. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. Journal of Infectious Diseases. 1999;180(6):1863-1868. https://doi.org/10.1086/315127
  34. Brotman RM, Klebanoff MA, Nansel TR,Yu KF, Andrews WW, Zhang J, Schwebke JR. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. Journal of Infectious Diseases. 2010;202(12):1907-1915. https://doi.org/10.1086/657320
  35. Donders GG, Van Bulck B, Caudron J, Londers L, Vereecken A, Spitz B. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. American Journal of Obstetrics and Gynecology. 2000;183(2):431-437.  https://doi.org/10.1067/mob.2000.105738
  36. Hay PE, Morgan DJ, Ison CA, Bhide SA, Romney M, McKenzie P, Pearson J, Lamont RF, Taylor-Robinson D. A longitudinal study of bacterial vaginosis during pregnancy. British Journal of Obstetrics and Gynecology. 1994;101(12):1048-1053. https://doi.org/10.1111/j.1471-0528.1994.tb13580.x
  37. Llahi-Camp JM, Rai R, Ison CA, Regan L. Association of bacterial vaginosis with a history of second trimester miscarriage. Human Reproduction. 1996;11(7):1575-1578. https://doi.org/10.1258/0956462971919363
  38. Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ. 1999;319(7204):220-223.  https://doi.org/10.1136/bmj.319.7204.220
  39. Nelson DB, Bellamy S, Odibo A, Nachamkin I, Ness RB, Allen-Taylor L. Vaginal symptoms and bacterial vaginosis (BV): how useful is self-report? Development of a screening tool for predicting BV status. Epidemiology and Infection. 2007;135(8):1369-1375. https://doi.org/10.1017/S095026880700787X
  40. Eckert LO, Moore DE, Patton DL, Agnew KJ, Eschenbach DA. Relationship of Vaginal Bacteria and Inflammation with Conception and Early Pregnancy Loss Following In-Vitro Fertilization. Infectious Diseases in Obstetrics and Gynecology. 2003;11(1):11-17. 
  41. van Oostrum N, De Sutter P, Meys J, Verstraelen H. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Human Reproduction. 2013;28(7):1809-1815. https://doi.org/10.1093/humrep/det096
  42. Zdrodowska-Stefanow B, Klosowska WM, Ostaszewska-Puchalska I, Bulhak-Koziol V, Kotowicz B. Ureaplasma urealyticum 79 and Mycoplasma hominis infection in women with urogenital diseases. Advances in Medical Sciences. 2006;51:250-253. 
  43. Donders G, Ruban K, Bellen G, Petricevic L. Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen. Journal of Perinatal Medicine. 2017;45(5):505-515.  https://doi.org/10.1515/jpm-2016-0111
  44. Waites KB, Xiao L, ParalanovV, Viscardi RM, Glass JI. Molecular Methods for the Detection of Mycoplasma and Ureaplasma Infections in Humans. Journal of Molecular Diagnostics. 2012;14(5):437-450.  https://doi.org/10.1016/j.jmoldx.2012.06.001
  45. Allen-Daniels MJ, Serrano MG, Pflugner LP, Fettweis JM, Prestosa MA, Koparde VN, Brooks JP, Strauss JF 3rd, Romero R, Chaiworapongsa T, Eschenbach DA, Buck GA, Jefferson KK. Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection. American Journal of Obstetrics and Gynecology. 2015;212(6):779-779.e13.  https://doi.org/10.1016/j.ajog.2015.01.032
  46. Gupta A, Gupta S, Mittal A, Chandra P, Gill AK. Correlation of mycoplasma with unexplained infertility. Archives of Gynecology and Obstetrics. 2009;280(6):981-985.  https://doi.org/10.1007/s00404-009-1042-z
  47. Horowitz S, Horowitz J, Mazor M, Porath A, Glezerman M. Ureaplasma urealyticum cervical colonization as a marker for pregnancy complications. International Journal of Gynecology and Obstetrics. 1995;48(1):15-19.  https://doi.org/10.1016/0020-7292(94)02236-4
  48. Donders GG. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. British Journal of Obstetrics and Gynecology. 2002;109:1-10.  https://doi.org/10.1111/j.1471-0528.2002.00432.x
  49. Mason MJ, Winter AJ. How to diagnose and treat aerobic and desquamative inflammatory vaginitis. Sexually Transmitted Infections. 2017;93:8-10.  https://doi.org/10.1136/sextrans-2015-052406
  50. Donders GG, Van CK, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, Van Lierde S. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009;116(10):1315-1324. https://doi.org/10.1111/j.1471-0528.2009.02237.x
  51. Blum Oehler G, Heesemann J, Kranzfelder D, Scheutz F, Hacker J. Characterization of Escherichia coli serotype O12:K1:H7 isolates from an immunocompetent carrier with a history of spontaneous abortion and septicemia. European Journal of Clinical Microbiology and Infectious Diseases. 1997;16:153-155.  https://doi.org/10.1111/j.1471-0528.2011.03020.x
  52. Deb K, Chaturvedi M, Jaiswal Y. A «minimum dose» of lipopolysaccharide required for implantation failure: assessment of its effect on the maternal reproductive organs and interleukin-1α expression in the mouse. Reproduction. 2004;128(1):87-97.  https://doi.org/10.1530/rep.1.00110
  53. Donders G, Bellen G, Rezeberga D. Aerobic vaginitis in pregnancy. BJOG. 2011;118(10);1163-1170. https://doi.org/10.1111/j.1471‐0528.2011.03020.x
  54. Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Critical Reviews in Microbiology. 2016;42(6):905-927.  https://doi.org/10.3109/1040841X.2015.1091805
  55. Roberts CL, Algert CS, Rickard KL, Morris JM. Treatment of vaginal candidiasis for the prevention of preterm birth: a systematic review and meta-analysis. Systematic Reviews. 2015;4:31.  https://doi.org/10.1186/s13643-015-0018-2

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.